Addition of pegylated interferon alfa-2a to an ongoing nucleos(t) ide treatment accelerates decrease of HBs-antigen levels in patients with chronic hepatitis B: Results from the PADD-ON study

Sprinzl, M. and Grambihler, A. and Teuber, G. and Antoni, C. and Zeuzem, S. and Discher, T. and Cornberg, M. and Berg, T. and Loehr, H. and Tacke, F. and Lammert, F. and Schott, E. and Berg, C. and Zizer, E. and Heyne, R. and Spengler, U. and Thimme, R. and Pathil, A. and Klinker, H. and Weigand, K. and Riedl, M. and Wosniok, J. and Alshuth, U. and Kittner, J. and Schuchmann, M. and Galle, P. R. (2018) Addition of pegylated interferon alfa-2a to an ongoing nucleos(t) ide treatment accelerates decrease of HBs-antigen levels in patients with chronic hepatitis B: Results from the PADD-ON study. JOURNAL OF HEPATOLOGY, 68 (Suppl1). S108-S109. ISSN 0168-8278, 1600-0641

Full text not available from this repository. (Request a copy)
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin I
Depositing User: Petra Gürster
Date Deposited: 30 Jun 2020 08:24
Last Modified: 30 Jun 2020 08:24
URI: https://pred.uni-regensburg.de/id/eprint/14757

Actions (login required)

View Item View Item